19 related articles for article (PubMed ID: 36038047)
1. Co-transplantation of autologous T
Park TY; Jeon J; Lee N; Kim J; Song B; Kim JH; Lee SK; Liu D; Cha Y; Kim M; Leblanc P; Herrington TM; Carter BS; Schweitzer JS; Kim KS
Nature; 2023 Jul; 619(7970):606-615. PubMed ID: 37438521
[TBL] [Abstract][Full Text] [Related]
2. Suppression of B-Cell Activation by Human Cord Blood-Derived Stem Cells (CB-SCs) through the Galectin-9-Dependent Mechanism.
Hu W; Song X; Yu H; Fan S; Shi A; Sun J; Wang H; Zhao L; Zhao Y
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339108
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Continuous Cervical Spinal Cord Stimulation Exerts Neuroprotective Effects in Experimental Parkinson's Disease.
Kuwahara K; Sasaki T; Yasuhara T; Kameda M; Okazaki Y; Hosomoto K; Kin I; Okazaki M; Yabuno S; Kawauchi S; Tomita Y; Umakoshi M; Kin K; Morimoto J; Lee JY; Tajiri N; Borlongan CV; Date I
Front Aging Neurosci; 2020; 12():164. PubMed ID: 32612523
[TBL] [Abstract][Full Text] [Related]
4. Carotid Body and Cell Therapy.
Lazarov NE; Atanasova DY
Adv Anat Embryol Cell Biol; 2023; 237():155-159. PubMed ID: 37946082
[TBL] [Abstract][Full Text] [Related]
5. Can pluripotent/multipotent stem cells reverse Parkinson's disease progression?
Wu Y; Meng X; Cheng WY; Yan Z; Li K; Wang J; Jiang T; Zhou F; Wong KH; Zhong C; Dong Y; Gao S
Front Neurosci; 2024; 18():1210447. PubMed ID: 38356648
[TBL] [Abstract][Full Text] [Related]
6. Human cord blood-derived multipotent stem cells (CB-SCs) treated with all-trans-retinoic acid (ATRA) give rise to dopamine neurons.
Li X; Li H; Bi J; Chen Y; Jain S; Zhao Y
Biochem Biophys Res Commun; 2012 Mar; 419(1):110-6. PubMed ID: 22330803
[TBL] [Abstract][Full Text] [Related]
7. Cerebral function of bone marrow multipotent adult progenitor cells after transplantation in Parkinson's disease rat models.
Zhang N; Zhou H; Wang H; Yu L; Li Z; Xu H; Wang M
Transplant Proc; 2013 Mar; 45(2):719-25. PubMed ID: 23498812
[TBL] [Abstract][Full Text] [Related]
8. Early Expression of Neuronal Dopaminergic Markers in a Parkinson's Disease Model in Rats Implanted with Enteric Stem Cells (ENSCs).
Parra-Cid C; Orozco-Castillo E; García-López J; Contreras-Figueroa E; Ramos-Languren LE; Ibarra C; Carreón-Rodríguez A; Aschner M; Königsberg M; Santamaría A
CNS Neurol Disord Drug Targets; 2020; 19(2):148-162. PubMed ID: 32303175
[TBL] [Abstract][Full Text] [Related]
9. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
[TBL] [Abstract][Full Text] [Related]
10. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
Han F; Wang W; Chen B; Chen C; Li S; Lu X; Duan J; Zhang Y; Zhang YA; Guo W; Li G
Cytotherapy; 2015 May; 17(5):665-79. PubMed ID: 25747741
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of human cord blood-derived multipotent stem cells (CB-SCs) enhances the recovery of Parkinson in rats.
Tang X; Li H; An B; Ma H; Huang N; Li X
Transpl Immunol; 2022 Dec; 75():101701. PubMed ID: 36038047
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
